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Background
Lynch syndrome (LS) is caused by heterozygous germ-
line mutations in the DNA mismatch repair (MMR)
genes and is a highly penetrant autosomal dominant
condition. A novel childhood cancer syndrome caused
by biallelic germline MMR gene mutations and charac-
terized by brain tumors, leukemias, gastrointestinal (GI)
polyposis, GI cancer and café-au-lait spots (CALS) has
been described. We reported the first biallelic kindred
in which 2 of 3 siblings proven to have a homozygous
germline MLH1 mutation, developed early-onset GI
cancer. In contrast to LS with clear GI screening and
surveillance recommendations, there are no recommen-
dations for surveillance of individuals with biallelic
mutations and no literature describing the long term
outcome.
Aim
To prospectively describe long-term outcome of our two
young patients with biallelic MMR mutations, and to
develop a generic cancer screening protocol for other
patients with biallelic MMR mutations.
Methods
On the basis of the molecular results, the 2 surviving sis-
ters and parents of a deceased child with metastatic duo-
denal cancer began a surveillance protocol based on our
crude estimates of cancer risks and available cancer
screening modalities.
Results
During endoscopic screening the youngest sister devel-
oped colonic polyps with high grade dysplasia and
underwent a subtotal colectomy with ileorectal anasto-
mosis. At 11 years she developed polyps in the duode-
num with low grade dysplasia which were excised
endoscopically. At 13 years of age, surveillance MRI
revealed a left parieto-occipital anaplastic astrocytoma
enabling total resection. Endoscopy in the older sister
who had a subtotal colectomy with ileorectal anastomo-
sis at 9 years of age for metastatic colorectal cancer has
low grade polyps in the duodenum, ileum and rectum
which were excised endoscopically. Gynecological fol-
low-up of both sisters with annual pelvic ultrasounds
have shown functional ovarian cysts. All neoplastic
lesions identified during surveillance were asymptomatic
at diagnosis. The sisters are currently fifteen and seven-
teen years old with no evidence of disease 10 years after
their brother’s diagnosis. The parents (43 and 44 years)
have annual colonoscopy with no evidence of polyps or
cancer. Gynecological screening for the mother has not
revealed any abnormalities. Based on our experience to
date and review of available literature, we have devel-
oped the screening guidelines shown in Table 1.
Conclusions
Biallelic carriers who participated in oncologic surveil-
lance had presymptomatic neoplasms identified and
treated. These siblings are alive with no evidence of dis-
ease at 10-year follow-up. Aggressive surveillance in
biallelic MMR carriers is feasible, allows early detection
and improves long-term survival.
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Table 1 Screening Guidelines
Cancer Recommendations
Colon Colonoscopy yearly*
Upper GI Tract and small bowel EGD yearly*
Video capsule endoscopy *
Brain+ MRI brain q 6 months
Leukemia+
Lymphoma+
CBC, DNA for T-cell and B-cell rearrangement, serum LDH q 3 to 6 months
Urinary tract Abdominal ultrasound at birth or diagnosis
EGD, Esophagogastroduodenoscopy.
*beginning at 3 years of age or at diagnosis with frequency determined by baseline findings.
+if diagnosed prenatally brain, leukemia/lymphoma screening should commence at birth.
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